$Esperion Therapeutics (ESPR.US)$ hi eveyone ? who knows thi...

DazzlerAus : hinestly it beggers belief this company is on a massive turnaround has some excellent distribution partners but just keeps falling

Growth Investor27 : $Esperion Therapeutics (ESPR.US)$ Give it time, Institutions & hedge funds have been accumulating & now own 73% of the outstanding shares, see FINTEL website. Today's news was actually very good, because Esperion is selling the drug at a profit to the Australian pharma company & It will generate immediate cash for Esperion. Daiichi Sankyo Europe will take over the cost of goods this year so that will drop the lower Esperions yearly expense by $50 to $100 million, I read it's $0.30c a pill loss for esperion supplying Daiichi.  Esperion low end prediction for 2025 for U.S sales is $140 million. They have $160 million cash now & they will get $130 million this year from Otsuka and royalties will start. In 2026 Esperion will generate a decent profit. I estimate ESPR will be above $10 a share by this time next year.  

Yi S : There is no good news; it's just that the organizers are tricking fools to Buy in.

元宝树 OP Yi S : I'm so scared.

元宝树 OP Growth Investor27 : Oh my, if I buy it now, I will have to wait until next year for it to arrive.

元宝树 OP Growth Investor27 : thank u !

Skyzero : Not this only..AVDL also